Thanks to less frequent injections and the fact that it is not inferior to Norditropin, Sogroya is gaining popularity among endocrinologists in the treatment of patients with growth failure.
This leaflet answers some common questions about Norditropin ® FlexPro ®. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果